Literature DB >> 27501127

Dexmedetomidine for the treatment of hyperactive delirium refractory to haloperidol in non-intubated patients.

Ryan O Parker1, Adam B King1, Christopher G Hughes2.   

Abstract

Entities:  

Year:  2016        PMID： 27501127      PMCID： PMC4958851          DOI： 10.21037/jtd.2016.05.47

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  15 in total

1.  Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement.

Authors:  Don C Des Jarlais; Cynthia Lyles; Nicole Crepaz
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

2.  Delirium in the intensive care unit: an under-recognized syndrome of organ dysfunction.

Authors:  E W Ely; M D Siegel; S K Inouye
Journal:  Semin Respir Crit Care Med       Date:  2001       Impact factor: 3.119

3.  Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.

Authors:  E Wesley Ely; Ayumi Shintani; Brenda Truman; Theodore Speroff; Sharon M Gordon; Frank E Harrell; Sharon K Inouye; Gordon R Bernard; Robert S Dittus
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

4.  Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.

Authors:  Valerie J Page; E Wesley Ely; Simon Gates; Xiao Bei Zhao; Timothy Alce; Ayumi Shintani; Jim Jackson; Gavin D Perkins; Daniel F McAuley
Journal:  Lancet Respir Med       Date:  2013-08-21       Impact factor: 30.700

5.  Costs associated with delirium in mechanically ventilated patients.

Authors:  Eric B Milbrandt; Stephen Deppen; Patricia L Harrison; Ayumi K Shintani; Theodore Speroff; Renée A Stiles; Brenda Truman; Gordon R Bernard; Robert S Dittus; E Wesley Ely
Journal:  Crit Care Med       Date:  2004-04       Impact factor: 7.598

6.  Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study).

Authors:  Yahya Shehabi; Peter Grant; Hugh Wolfenden; Naomi Hammond; Frances Bass; Michelle Campbell; Jack Chen
Journal:  Anesthesiology       Date:  2009-11       Impact factor: 7.892

7.  Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.

Authors:  Richard R Riker; Yahya Shehabi; Paula M Bokesch; Daniel Ceraso; Wayne Wisemandle; Firas Koura; Patrick Whitten; Benjamin D Margolis; Daniel W Byrne; E Wesley Ely; Marcelo G Rocha
Journal:  JAMA       Date:  2009-02-02       Impact factor: 56.272

8.  Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Brenda T Pun; Daniel L Herr; Mervyn Maze; Timothy D Girard; Russell R Miller; Ayumi K Shintani; Jennifer L Thompson; James C Jackson; Stephen A Deppen; Renee A Stiles; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  JAMA       Date:  2007-12-12       Impact factor: 56.272

9.  Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.

Authors:  Timothy D Girard; Pratik P Pandharipande; Shannon S Carson; Gregory A Schmidt; Patrick E Wright; Angelo E Canonico; Brenda T Pun; Jennifer L Thompson; Ayumi K Shintani; Herbert Y Meltzer; Gordon R Bernard; Robert S Dittus; E Wesley Ely
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

10.  Haloperidol prophylaxis in critically ill patients with a high risk for delirium.

Authors:  Mark van den Boogaard; Lisette Schoonhoven; Theo van Achterberg; Johannes G van der Hoeven; Peter Pickkers
Journal:  Crit Care       Date:  2013-01-17       Impact factor: 9.097
View more
  2 in total

1.  Dexmedetomidine, agitated delirium, and "off-label" drugs.

Authors:  Genís Carrasco; Nacho Baeza; Lluís Cabré
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial.

Authors:  Yang Deng; Zhijun Qin; Qianyun Wu; Linsong Liu; Xi Yang; Xuan Ju; Ying Zhang; Lei Liu
Journal:  Drug Des Devel Ther       Date:  2022-08-01       Impact factor: 4.319
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.